PURE Bioscience, Inc. (PURE)

Revenue by Segment

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020	Jul 31, 2019	Jul 31, 2018	Jul 31, 2017	Jul 31, 2016
Manufacture and Distribution of its Products	2.20M	1.96M	1.88M	1.85M	3.93M
Manufacture and Distribution of its Products Growth	12.18%	4.58%	1.30%	-52.81%	-43.23%
Total	2.20M	1.96M	1.88M	1.85M	3.93M
Total Growth	12.18%	4.58%	1.30%	-52.81%	-43.23%

Revenue by Geography

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020	Jul 31, 2019	Jul 31, 2018	Jul 31, 2017	Jul 31, 2016
United States	2.20M	1.96M	1.88M	1.81M	3.70M
United States Growth	12.18%	4.58%	3.53%	-50.97%	-45.45%
Total	2.20M	1.96M	1.88M	1.81M	3.70M
Total Growth	12.18%	4.58%	3.53%	-50.97%	-46.54%

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 13, 2026

Data Sources Report a data error